1. Adherence and persistence to rivaroxaban in non-valvular atrial fibrillation patients receiving 30- or 90-day supply prescription fills. (2nd January 2022) Authors: Coleman, Craig I.; Bunz, Thomas J.; Ashton, Veronica Journal: Current medical research and opinion Issue: Volume 38:Number 1(2022) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Association between rivaroxaban use and length of hospital stay, treatment costs and early outcomes in patients with pulmonary embolism: a systematic review of real-world studies. (2nd September 2017) Authors: Kohn, Christine G.; Fermann, Gregory J.; Peacock, W. Frank; Wells, Phil S.; Baugh, Christopher W.; Ashton, Veronica; Crivera, Concetta; Schein, Jeff R.; Wildgoose, Peter; Coleman, Craig I. Journal: Current medical research and opinion Issue: Volume 33:Number 9(2017) Page Start: 1697 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II. (November 2017) Authors: Gitt, Anselm K.; Lautsch, Dominik; Ferrières, Jean; De Ferrari, Gaetano M.; Vyas, Ami; Baxter, Carl A.; Bash, Lori D.; Ashton, Veronica; Horack, Martin; Almahmeed, Wael; Chiang, Fu-Tien; Poh, Kian Keong; Brudi, Philippe; Ambegaonkar, Baishali Journal: Atherosclerosis Issue: Volume 266(2017) Page Start: 158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cost comparison of continued anticoagulation with rivaroxaban versus placebo based on the 1-year EINSTEIN-Extension trial efficacy and safety results. (3rd June 2018) Authors: Wells, Philip S.; Lensing, Anthonie W. A.; Haskell, Lloyd; Levitan, Bennett; Laliberté, François; Durkin, Michael; Ashton, Veronica; Xiao, Yongling; Crivera, Concetta; Lejeune, Dominique; Schein, Jeff; Lefebvre, Patrick Journal: Journal of medical economics Issue: Volume 21:Number 6(2018) Page Start: 587 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effectiveness and safety of rivaroxaban versus warfarin in obese nonvalvular atrial fibrillation patients: analysis of electronic health record data. (2nd July 2020) Authors: Costa, Olivia S.; Beyer-Westendorf, Jan; Ashton, Veronica; Milentijevic, Dejan; Moore, Kenneth Todd; Bunz, Thomas J.; Coleman, Craig I. Journal: Current medical research and opinion Issue: Volume 36:Number 7(2020) Page Start: 1081 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Healthcare costs of stroke and major bleeding in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants. (3rd August 2019) Authors: Rozjabek, Heather M.; Coleman, Craig I.; Ashton, Veronica; Laliberté, François; Oyefesobi, Paul; Lejeune, Dominique; Germain, Guillaume; Schein, Jeff R.; Yuan, Zhong; Lefebvre, Patrick; Peterson, Eric D. Journal: Journal of medical economics Issue: Volume 22:Number 8(2019) Page Start: 751 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Healthcare resource utilization and costs among nonvalvular atrial fibrillation patients initiating rivaroxaban or warfarin in skilled nursing facilities: a retrospective cohort study. (2nd April 2020) Authors: Mittal, V. Simon; Wu, Bingcao; Song, Ji; Milentijevic, Dejan; Ashton, Veronica; Mahajan, Dheeraj Journal: Current medical research and opinion Issue: Volume 36:Number 4(2020) Page Start: 529 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Healthcare resource utilization and costs of rivaroxaban versus warfarin among non-valvular atrial fibrillation (NVAF) patients with obesity in a US population. (1st January 2021) Authors: Berger, Jeffrey S.; Laliberté, François; Kharat, Akshay; Lejeune, Dominique; Moore, Kenneth Todd; Jung, Young; Lefebvre, Patrick; Ashton, Veronica Journal: Journal of medical economics Issue: Volume 24:Number 1(2021) Page Start: 550 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Impact of renal function on ischemic stroke and major bleeding rates in nonvalvular atrial fibrillation patients treated with warfarin or rivaroxaban: a retrospective cohort study using real-world evidence. (3rd October 2017) Authors: Weir, Matthew R.; Berger, Jeffrey S.; Ashton, Veronica; Laliberté, François; Brown, Kip; Lefebvre, Patrick; Schein, Jeffrey Journal: Current medical research and opinion Issue: Volume 33:Number 10(2017) Page Start: 1891 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Importance of balancing follow-up time and impact of oral-anticoagulant users' selection when evaluating medication adherence in atrial fibrillation patients treated with rivaroxaban and apixaban. (3rd June 2017) Authors: Coleman, Craig; Yuan, Zhong; Schein, Jeff; Crivera, Concetta; Ashton, Veronica; Laliberté, François; Lefebvre, Patrick; Peterson, Eric D. Journal: Current medical research and opinion Issue: Volume 33:Number 6(2017) Page Start: 1033 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗